Powerpoint slide presentations are available for selected DOPPS publications. In
our mission to share research and scientific knowledge, we encourage you to
download and use DOPPS slides. If you intend to use slides in a presentation or publication, we ask that you properly cite the source, and do not alter the slides in any way that might confuse the meaning or source of the statistics. If possible, please also provide information on where and how you intend to use the slides
in the Contact Us section of this site.
Total Records: 92; Page 1 of 10
Title | Media | Authors | Journal | Publication Year |
| Atrial fibrillation in hemodialysis patients. clinical features and associations with anticoagulant therapy | On Web Slides | Wizemann V, Tong L, Satayathum S, Disney A, Fissell RB, Kerr PG, Young EW, Robinson BM | Kidney International | 2010 |
| International trends in erythropoietin use and hemoglobin levels in hemodialysis patients | On Web Slides | McFarlane PA, Pisoni RL, Eichleay MA, Wald R, Port FK, Mendelssohn DC | Kidney International | 2010 |
| Facility hemodialysis vascular access use and mortality in countries participating in DOPPS: An instrumental variable analysis | On Web Slides | Pisoni RL, Arrington CJ, Albert JM, Ethier J, Kimata N, Krishnan M, Rayner HC, Saito A, Sands J, Saran R, Gillespie BW, Wolfe RA, Port FK | American Journal of Kidney Diseases | 2009 |
| The Key comorbid conditions that are predictive of survival among hemodialysis patients | On Web Slides | Miskulin D, Bragg-Gresham JL, Gillespie BW, Tentori F, Pisoni RL, Tighiouart H, Levey A, Port FK | Clinical Journal of the American Society of Nephrology | 2009 |
| The burden of amputation among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study | On Web Slides | Combe C, Albert JM, Bragg-Gresham JL, Andreucci VE, Disney A, Fukuhara S, Goodkin DA, Gillespie BW, Saito A, Jadoul M, Pisoni RL | American Journal of Kidney Diseases | 2009 |
| Prescription of antihypertensive agents to hemodialysis patients: Time trends and associations with patient characteristics, country, and survival in the DOPPS | On Web Slides | Lopes AA, Bragg-Gresham JL, Ramirez SPB, Andreucci VE, Akiba T, Saito A, Jacobson SH, Robinson BM, Port FK, Mason NA, Young EW | Nephrology Dialysis Transplantation | 2009 |
| Rosiglitazone is associated with mortality in chronic hemodialysis patients | On Web Slides | Ramirez SPB, Albert JM, Blayney M, Tentori F, Goodkin DA, Wolfe RA, Young EW, Bailie GR, Pisoni RL, Port FK | Journal of the American Society of Nephrology | 2009 |
| Conversion of vascular access type among incident hemodialysis patients: Description and association with mortality | On Web Slides | Bradbury BD, Chen F, Furniss AL, Pisoni RL, Keen ML, Mapes DL, Krishnan M | American Journal of Kidney Diseases | 2009 |
| Greater first-year survival on hemodialysis in facilities in which patients are provided earlier and more frequent pre-nephrology visits. | On Web Slides | Hasegawa T, Bragg-Gresham JL, Yamazaki S, Fukuhara S, Akizawa T, Kleophas W, Greenwood RN, Pisoni RL | Clinical Journal of the American Society of Nephrology | 2009 |
| The survival advantage for hemodialysis patients taking vitamin D is questioned: Findings from the Dialysis Outcomes and Practice Patterns Study | On Web Slides | Tentori F, Albert JM, Young EW, Blayney M, Robinson BM, Pisoni RL, Akiba T, Greenwood RN, Kimata N, Levin NW, Piera L, Saran R, Wolfe RA, Port FK | Nephrology Dialysis Transplantation | 2009 |
|
To view the slides, you need to have Microsoft® Powerpoint Viewer. To
download the free version, click here. Then click the "Powerpoint Viewer" link.
|
The DOPPS Annual Report
The DOPPS Annual Report portrays descriptive statistics for multiple, representative cross-sectional cohorts over several practice areas, from anemia to vascular access.
|
DOPPS Presentations of Published Research
|
|
Coordinated by research scientists
and staff of Arbor Research Collaborative
for Health, and supported by research grants from Amgen (since 1996),
Kyowa Hakko Kirin (since 1999, in Japan), Genzyme (since 2009), and Abbott (since 2009) without
restrictions on publications.
|
|